
Monthly zzso activity and clinical disability were evaluated in two zzso multiple sclerosis zzso patients for 4 years during a zzso treatment trial with zzso and for a mean of 21 months after terminating treatment with zzso zzso zzso activity was compared to baseline activity in these zzso Although contrast enhancing zzso zzso and the bulk white matter zzso load zzso on zzso images eventually returned to baseline values, there was a zzso period of 6 - 10 months after terminating treatment, before baseline zzso activity was zzso Although the mechanism for a sustained effect of zzso is unclear at this time, these results have important implications for enrollment of such patients into new treatment protocols that rely on contrast enhancing zzso frequency as an outcome zzso 

